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ABSTRACT 
A simple, accurate, economical, fast and reliable method 
for the determination of lercanidipine (LR) is highly 
desirable to support formulation screening and quality 
control. The method was developed for determination of 
LR in pure drug and tablet dosage form. Best results 
were shown in terms of linearity, accuracy, precision, 
LOD and LOQ for pure drug as well as for tablets. UV 
absorbance was measured at 332 nm. Excellent linearity 
(correlation coefficient (r2) = 0.9970) found in the 
concentration range of 7.5-60 µg/ml. The LOD and LOQ 
were 1.0770 and 3.2638 µg/ml respectively and good 
recoveries were achieved (95.779%). 
 
KEYWORDS:  Lercanidipine, Methanol, Zero order 
spectra, First derivative zero crossing spectrophotomet
INTRODUCTION 
 
Figure 1 is structure of  Lercanidipine (LR), which 
is 2-[(3,3-diphenylpropyl)methylamine]-1,1-
dimethylethylmethyl1,4-dihydro-2,6-dimethyl-4-(3-
nitrophenyl)-3,5pyridinedicarboxylic ester and belongs 
to well-known pharmacological active compound series 
classified as 1,4-dihydropyridine calcium channel 
blockers. It is used as anti-hypertensive agent (1,2) as it 
has good specificity on the smooth vascular cells (3). The 
molecular weight of LR is 648.19 and melting point is 
170-180 °C (4).  
It is soluble in chloroform, methanol and 
acetonitrile and practically insoluble in water (5). LR 
exhibited high affinity for the dihydropyridine (DHP) 
subunit of the L-type calcium channel (6). The aim of the 
present work is to investigate utility of derivative 
spectrophotometry and to develop validated 
spectrophotometric procedures for determination of LR 
either in pure drug or in tablet dosage forms. 
1. EXPERIMENTAL 
1.1 Apparatus 
 
Spectrophotometeric measurements were made on a 
Shimadzu 1700 double beam UV Visible 
spectrophotometer with a fix slit width of 1 nm coupled 
with computer loaded with Shimadzu UV PC software 
(UV probe) version 2.31.  
 
1.2 Materials 
 
1.2.1 pure samples 
 
LR was kindly supplied by the Alembic pharmaceuticals 
Ltd. Vadodara, India.  
 
1.2.2 Market samples 
 
The marketed formulation of LR was obtained 
commercially from Sun Pharmaceuticals Ltd (Lotensyl-
10 labeled 10 mg of pure drug, Batch Number- 
AD80120). 
 
1.2.3 Chemical and reagents 
 
AR grade methanol was used as a solvent for 
spectrophotometric work. 
 
2.3 Preparation of standard and sample solutions 
 
Stock solution of 1 mg/ml of pure LR and its formulation 
was freshly prepared in methanol. Test solution of LR 
was tested for stability in solution during the actual 
analysis. The behaviour of LR was found to be stable 
over the period of 24 hr from their preparation at room 
temperature.  
 
2.4 Procedure 
 
2.4.1 First derivative zero crossing 
spectrophotometry  
 
The Zero order spectra of the LR were recorded 
between 200-400 nm against blank (AR grade methanol) 
using a 1.0 cm quartz cell. The zero order spectra of pure 
LR were stored individually within the 7.5-60 µg/ml 
concentration ranges and were derivatized in first order 
using delta lambda 4 and scaling factor 10. The first 
derivative amplitudes were recorded at 332 nm 
 
3 Results and Discussion 
It is observed from the absorption spectra of the LR 
that it has a good linearity in the range of 7.5-60 µg/ml. 
Figure 2 describes the 1st derivative spectra of LR. This 
method was validated; all the validation parameters were 
in limit as per the ICH guidelines (7). Table 1 exhibits 
the detailed validation parameters of the methods.  
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                              Figure 1. Structure of the LR. 
 
 
      
 
 
Table 1. Validation parameters results obtained by the method 
 
 
Figure 2. First order derivative spectra of LR. 
 
4 Conclusion 
 
The newly developed spectrophotometeric method 
for determination of LR is simple, specific, accurate, 
precise, rapid and economical which indicates its 
adequacy for routine Pharmaceutical analysis. It is 
concluded that derivative spectrophotometery is 
successfully utilized for the estimation of LR. 
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Validation Parameters Result 
 Absorption maxima, 
ƛ max (nm) 
 
332 
 
Linearity range (µg/ml) 
 
7.5-60 
 
Coefficientof 
determination (r2) 
 
0.9970 
 
Regression equation (Ya) 
 
Y=0.002X+0.003 
 
Slope (b) 
 
0.002 
 
Intercept (a) 
 
0.003 
 
Limit of detection LOD, 
(µg/ml) 
1.0770 
 
Limit of quantitation 
LOQ (µg/ml) 
3.2638 
 
Accuracy (%) 95.779 
 
JPRHC  
Research Article 
 
JPRHC                                                          VOLUME 2                                         ISSUE 3                                      263-265 
REFERENCES 
(1) McClellan KJ, Jarvis B. Lercanidipine: A Review of 
its Use in Hypertension. Ingenta 
connect,2000,60,1123-1140. 
(2) Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei 
C, Leonardi A, Testa R. In Vitro        Calcium 
Antagonist Activity of Lercanidipine and Its 
Enantiomers. Journal of Cardiovascular 
Pharmacology,1997,29,S10-S18.  
(3) Bianchi G, Passoni A, Griffini PL. Effects of a new 
calcium antagonist on cardiac contractility of 
conscious rabbits. Pharmacol Res,1989,21,193-
200. 
(4) Ambemethy, Schwartz JB. Calcium Antagonist 
Drugs. The New England Jounral of 
Medicine,1999, 341,1447-57. 
(5) Mihaljica S, Radulovic D, Trbojevic J. 
Determination of Lercanidipine Hydrochloride and 
Its Impurities in Tablets. 
Chromatographia,2005,61,25–29. 
(6) lvarez LA, Pujol S, Squella J, Nu´n˜ez VL. A 
selective HPLC method for determination of 
lercanidipine in tablets. Journal of pharmaceutical 
and biomedical analysis,2003,31,1-9. 
(7) International Conference on Harmonization (ICH), 
Validation of Analytical Procedures: 
Methodology. (1996) Q2 B.   
 
 
AUTHORS AFFILIATIONS AND ADDRESS FOR 
COMMUNICATION: 
1Department of Pharmaceutical Analysis,  I.S.F. 
Analytical Laboratory, I.S.F. College of Pharmacy, 
Ferozepur Road, Ghal Kalan, Moga 142001, PUNJAB 
Phone: +91 1636 324200 324201, +91 9779300464 
TeleFax: +91 1636 236564 
*Email: artirthakkar@gmail.com 
 
 
 
